INTERPACE BIOSCIENCES, INC.
IDXGOTCHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $38.7M | $10.2M | $9.7M | $31.8M | $33.1M | $32.4M |
| Operating income | $4.1M | $1.1M | $838,000 | −$3.6M | −$6.3M | −$26.1M |
| Net income | $24.6M | $708,000 | $514,000 | −$22.0M | −$14.9M | −$26.5M |
| Total assets | $33.8M | $12.1M | $16.0M | $16.0M | $38.4M | $45.7M |
| Total liabilities | $11.5M | $20.4M | $26.8M | $32.5M | $34.3M | $28.2M |
| Equity | $22.4M | −$54.8M | −$57.4M | −$58.1M | −$42.4M | −$29.1M |
| EPS (diluted) | $0.89 | $0.16 | $0.12 | $-5.18 | $-3.61 | — |
| Shares out. | 4.4M | 4.4M | 4.3M | 4.2M | 4.1M | 4.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 10.5%
- Net margin
- 63.5%
- Return on equity
- 109.9%
- Return on assets
- 72.6%
- Return on capital (ROCE)
- 14.2%
- Liabilities / assets
- 33.9%
- Debt / equity
- 0.51×
- Book value / share
- $5.06
- Revenue growth (YoY)
- 280.5%
- Net income growth (YoY)
- 3371.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -16.52distress
- Accruals / assets
- 55.4%high accruals
- Beneish M-Score
- 3.62elevated
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 2 warning● 5 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High accruals — earnings-quality risk
- Beneish M-Score elevated — earnings-manipulation screen flag
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2021
- NT 10-Qmissed a reporting deadline ↗Nov 17, 2020
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2020
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2016
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Singer Douglas MarkPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 806 | 1.0 | +30.8% |
| Apr 30, 2026 | 616 | 1.0 | -77.9% |
| Apr 15, 2026 | 2,793 | 1.0 | -47.5% |
| Mar 31, 2026 | 5,317 | 1.0 | -17.6% |
| Mar 13, 2026 | 6,456 | 1.0 | +11638.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 14, 2026
- Results of operationsApr 1, 2026
- Results of operations · Regulation FD disclosureJan 20, 2026
- Other material eventDec 3, 2025
- Results of operationsNov 12, 2025
- Results of operationsAug 8, 2025
- Results of operationsMay 8, 2025
- Costs from exit or disposal · Other material eventMay 1, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.